Clinical Trial Update: Phase I Study of BMS-690514 in Japanese Patients With Solid Tumors [Phase 1]

View source ↗

Summary

This trial update notes the completion of a Phase I study of BMS-690514 in Japanese patients with solid tumors. It was sponsored by Bristol-Myers Squibb.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• BMS-690514

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Cancer | Phase 1 | Status: COMPLETED